Table of contents
March 2004 Vol 4 No 3
In this issue
p167 | doi:10.1038/nrc1315
Research Highlights
Tumour suppressors: Conflict resolution
p169 | doi:10.1038/nrc1304
Tumorigenesis: Nuisance neighbours
p170 | doi:10.1038/nrc1305
Therapeutics: Overcoming inhibition
p170 | doi:10.1038/nrc1312
Web Watch
COSMIC collection
p170 | doi:10.1038/nrc1314
In brief
Early Detection | Metastasis | Therapeutics | Immunotherapy
p171 | doi:10.1038/nrc1310
Metastasis: Migratory cues
p172 | doi:10.1038/nrc1302
Angiogenesis: Going for the double
p172 | doi:10.1038/nrc1303
Tumour suppressors: A topsy-turvy world
p173 | doi:10.1038/nrc1308
Mathematical models: Accelerating cancer understanding
p174 | doi:10.1038/nrc1306
In the news
Deodorant debate rages on
p174 | doi:10.1038/nrc1311
Pharmacogenetics: Small change, large effect
p175 | doi:10.1038/nrc1309
Trial Watch
Debugged | Insufficient evidence
p175 | doi:10.1038/nrc1313
Reviews
A census of human cancer genes
P. Andrew Futreal, Lachlan Coin, Mhairi Marshall, Thomas Down, Timothy Hubbard, Richard Wooster, Nazneen Rahman & Michael R. Stratton
p177 | doi:10.1038/nrc1299
Tumour-suppressor function in the nervous system
Suzanne J. Baker & Peter J. McKinnon
p184 | doi:10.1038/nrc1297
Dynamics of cancer progression
Franziska Michor, Yoh Iwasa & Martin A. Nowak
p197 | doi:10.1038/nrc1295
Diet and cancer — the European Prospective Investigation into Cancer and Nutrition
Sheila Bingham & Elio Riboli
p206 | doi:10.1038/nrc1298
Targeting the checkpoint kinases: chemosensitization versus chemoprotection
Bin-Bing S. Zhou & Jiri Bartek
p216 | doi:10.1038/nrc1296
Perspectives
Opinion
Cancer as a robust system: implications for anticancer therapy
Hiroaki Kitano
p227 | doi:10.1038/nrc1300
Science and society
Genetic testing for cancer susceptibility: the promise and the pitfalls
Caryn Lerman & Alexandra E. Shields
p235 | doi:10.1038/nrc1301